WHO ICTRP trial
Inhibitory effect of needling sphenopalatine ganglion on the over activation of…
ChiCTR2300073792 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300073792 |
|---|---|
| Public title | Inhibitory effect of needling sphenopalatine ganglion on the over activation of mucosal cells’ NF-kB signaling pathway in patients with allergic rhinitis |
| Scientific title | Inhibitory effect of needling sphenopalatine ganglion on the over activation of mucosal cells’ NF-kB signaling pathway in patients with allergic rhinitis |
| Primary sponsor | Beijing Tongren Hospital affiliated to Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Allergic Rhinitis |
| Interventions | Treatment group :Needling Sphenopalatine Ganglion;Control group:puncturing Xiaguan acupoint |
| Registration date | Jul 20, 2023 |
| Target size | Treatment group :30;Control group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: